<?xml version="1.0" encoding="UTF-8"?>
<p>In 2017, it was shown that remdisiver could prevent the replication of SARS and MERS coronaviruses and be effective against bat and circulating contemporary human coronaviruses in vitro.
 <xref rid="cit0017" ref-type="bibr">17</xref> In mice, prophylactic and early therapeutic administration of remdesivir significantly decreased the pulmonary viral loads and improved the clinical symptoms of the disease and lung function. It was concluded that remdesivir might be effective against endemic MERS coronavirus, circulating human coronaviruses and, in particular, emerging coronaviruses in the future.
 <xref rid="cit0017" ref-type="bibr">17</xref>
</p>
